LONDON (MarketWatch) -- Pfizer Inc. said that the U.K. National Institute for Health and Clinical Excellence has recommended its Champix (varenicline) treatment for use on the National Health Service.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback